ACM
MIST icon

ADAR1 Capital Management’s Milestone Pharmaceuticals MIST Stock Holding History

ADAR1 Capital Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$119K Sell
100,000
-100
-0.1% -$175 0.01% 282
2025
Q4 		$202K Buy
+100,100
New +$216K 0.01% 229
2024
Q4 		– Sell
-27,931
Closed -$42.5K – 269
2024
Q3 		$42.5K Sell
27,931
-174,529
-86% -$254K 0.01% 223
2024
Q2 		$267K Hold
202,460
– – 0.05% 129
2024
Q1 		$362K Buy
+202,460
New +$329K 0.08% 93

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

ADAR1 Capital Management's MIST Position: Q1 2026 in Review

ADAR1 Capital Management reduced its Milestone Pharmaceuticals (MIST) stake by 0.1% in Q1 2026, selling an estimated $175 and leaving 100,000 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #282.

ADAR1 Capital Management first reported a position in MIST in Q1 2024 and has held it in 5 quarters since. The position peaked at $362K in Q1 2024. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • ADAR1 Capital Management held 100,000 shares of Milestone Pharmaceuticals worth $119K as of Q1 2026.
  • ADAR1 Capital Management sold 100 Milestone Pharmaceuticals shares in Q1 2026, an estimated $175.
  • Milestone Pharmaceuticals made up 0.01% of ADAR1 Capital Management's portfolio in Q1 2026, its #282 holding.
  • ADAR1 Capital Management first reported a position in Milestone Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • ADAR1 Capital Management's Milestone Pharmaceuticals position peaked at $362K in Q1 2024.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.